The Dana-Farber Cancer Institute has received a $5 million gift from the Edward P. Evans Foundation in support of research on myelodysplastic syndromes (MDS).
What is MDS?
A group of bone marrow disorders that impact the body’s ability to generate sufficient amounts of healthy red blood cells, about 20% of those suffering from MDS will develop acute myeloid leukemia (AML).
The Only Cure to Date
Thus far the only known cure for MDS is a bone marrow transplant from a healthy donor—but fewer than 10% of those afflicted by the disease can undergo a transplant due to advanced age or a specific medical problem reports Philanthropy News Digest.
The Edwards P. Evans Center for Myelodysplastic Syndromes at Dana-Farber
The funds from the Newton-based foundation will now establish The Edwards P. Evans Center for Myelodysplastic Syndromes at Dana-Farber which capitalizes on the fact that the clinical research center has a longstanding track record conducting MDS-related research.
The Edward P. Evans Foundation Comment
“Since 2011, the Edward P. Evans Foundation has contributed more than $66 million to medical research directed at improving outcomes and finding a cure for MDS patients” noted Michael D. Lewis, president of the foundation. Ms. Lewis continued “Dana-Farber Cancer Institute is the ideal location for our newest Edward P. Evans Center for Myelodysplastic Syndromes, part of the foundations next chapter in forwarding this research.
Who is the Edward P. Evans Foundation?
The Edward P. Evans Foundation was established in 1984 to facilitate philanthropic interests following Ms. Edward Evans death on December 31, 2010. Mr. Evans accumulated large sums of money in business and during his lifetime contributed greatly to institutions such as Yale University Press, Yale University, Harvard Business School and various medical and equine charities. He was an early supporter of CapCure (later to become the Prostate Cancer Foundation). He pledged $50 million to Yale for the construction of the Edward P. Evans Hall.
Mr. Evans died in 2010 from Acute Myelogenous Leukemia.